Brentuximab 50mg
| Product Overview | |
| Generic Name | Brentuximab 50mg |
| Brand Name(s) | Adcetris, Aark |
| Form | IV lyophilized injection vials |
| Strength | 50 mg/vial |
| Therapeutic Class | Antibody–drug conjugate; |
| ATC Code | L01FX05 |
| Manufacturing & Regulatory | |
| Manufacturer | Seagen, Takeda |
| GMP Compliance | FDA/EMA/WHO-GMP |
| DMF/CEP | Type II |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | Pack of 25 |
| Shelf Life | 24 months |
| Storage | 2–8 °C, protect from light |
| Incoterms | Ex-works Mex |
| Lead Time | 7 - 10 days |
| Documentation | |
| Certificate of Analysis (COA) | Yes |
| SDS | Upon Request |
| CTD Summary | Upon Request |
Description
Indications/Usage: Hodgkin lymphoma, ALCL, CTCL
